166 related articles for article (PubMed ID: 32538430)
1. Dexmedetomidine exerts neuroprotective effects during high glucose-induced neural injury by inhibiting miR-125b.
Hou X; Xu F; Zhang C; Shuai J; Huang Z; Liang Y; Xu X
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32538430
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of dexmedetomidine on neuronal hypoxic injury through inhibition of miR-134.
Li YJ; Zhang DZ; Xi Y; Wu CA
Hum Exp Toxicol; 2021 Dec; 40(12):2145-2155. PubMed ID: 34121490
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine had neuroprotective effects on hippocampal neuronal cells via targeting lncRNA SHNG16 mediated microRNA-10b-5p/BDNF axis.
Wang L; Liu W; Zhang Y; Hu Z; Guo H; Lv J; Du H
Mol Cell Biochem; 2020 Jun; 469(1-2):41-51. PubMed ID: 32323054
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA cerebellar degeneration-related protein 1 antisense RNA (Circ-CDR1as) downregulation induced by dexmedetomidine treatment protects hippocampal neurons against hypoxia/reoxygenation injury through the microRNA-28-3p (miR-28-3p)/tumor necrosis factor receptor-associated factor-3 (TRAF3) axis.
Wang J; Wang Y
Bioengineered; 2021 Dec; 12(2):10512-10524. PubMed ID: 34787053
[TBL] [Abstract][Full Text] [Related]
5. MiR-29b expression is associated with a dexmedetomidine-mediated protective effect against oxygen-glucose deprivation-induced injury to SK-N-SH cells in vitro.
Huang Z; Liu G; Zeng Q; Gao R; Zhang S; Wang L; Liu B; Yu Y; Zhao A; Li R; Zhou S; Yu W
Cell Biol Int; 2018 Mar; 42(3):344-352. PubMed ID: 29087603
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine protects PC12 cells from oxidative damage through regulation of miR-199a/HIF-1α.
Wu L; Xi Y; Kong Q
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):506-514. PubMed ID: 32024386
[No Abstract] [Full Text] [Related]
7. Dexmedetomidine attenuates oxygen-glucose deprivation/ reperfusion-induced inflammation through the miR-17-5p/ TLR4/ NF-κB axis.
Suo L; Wang M
BMC Anesthesiol; 2022 Apr; 22(1):126. PubMed ID: 35488217
[TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine alleviates oxidative stress and mitochondrial dysfunction in diabetic peripheral neuropathy via the microRNA-34a/SIRT2/S1PR1 axis.
Lin Y; Wei Y; Wei Y; Yu H; Zhang W; Li C; He Y; Yao G; Zhang Y
Int Immunopharmacol; 2023 Apr; 117():109910. PubMed ID: 37012886
[TBL] [Abstract][Full Text] [Related]
9. miR‑223‑3p/TIAL1 interaction is involved in the mechanisms associated with the neuroprotective effects of dexmedetomidine on hippocampal neuronal cells in vitro.
Wang Q; Yu H; Yu H; Ma M; Ma Y; Li R
Mol Med Rep; 2019 Feb; 19(2):805-812. PubMed ID: 30569136
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of miRNA-151-3p enhanced the neuroprotective effect of dexmedetomidine against β-amyloid by targeting DAPK-1 and TP53.
Guo Y; Wu Y; Li N; Wang Z
Exp Mol Pathol; 2021 Feb; 118():104587. PubMed ID: 33275947
[TBL] [Abstract][Full Text] [Related]
11. MiR-125b-5p is involved in oxygen and glucose deprivation injury in PC-12 cells via CBS/H
Shen Y; Shen Z; Guo L; Zhang Q; Wang Z; Miao L; Wang M; Wu J; Guo W; Zhu Y
Nitric Oxide; 2018 Aug; 78():11-21. PubMed ID: 29777774
[TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine improves propofol-induced neuronal injury in rat hippocampus with the involvement of miR-34a and the PI3K/Akt signaling pathway.
Xing N; Xing F; Li Y; Li P; Zhang J; Wang D; Zhang W; Yang J
Life Sci; 2020 Apr; 247():117359. PubMed ID: 32001264
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-214-5p involves in the protection effect of Dexmedetomidine against neurological injury in Alzheimer's disease via targeting the suppressor of zest 12.
Hu G; Shi Z; Shao W; Xu B
Brain Res Bull; 2022 Jan; 178():164-172. PubMed ID: 34715270
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective Effects of Dexmedetomidine Preconditioning on Oxygen-glucose Deprivation-reoxygenation Injury in PC12 Cells via Regulation of Ca
Hu YD; Tang CL; Jiang JZ; Lv HY; Wu YB; Qin XD; Shi S; Zhao B; Zhu XN; Xia ZY
Curr Med Sci; 2020 Aug; 40(4):699-707. PubMed ID: 32862381
[TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine pretreatment alleviates ropivacaine-induced neurotoxicity via the miR-10b-5p/BDNF axis.
Xu W; Li X; Chen L; Luo X; Shen S; Wang J
BMC Anesthesiol; 2022 Sep; 22(1):304. PubMed ID: 36163004
[TBL] [Abstract][Full Text] [Related]
16. Dexmedetomidine Attenuates Hypoxia/Reoxygenation Injury of H9C2 Myocardial Cells by Upregulating miR-146a Expression via the MAPK Signal Pathway.
Chu Y; Teng J; Feng P; Liu H; Wang F; Wang H
Pharmacology; 2022; 107(1-2):14-27. PubMed ID: 34718238
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of dexmedetomidine against diabetic hyperglycemia-exacerbated cerebral ischemia/reperfusion injury: An in vivo and in vitro study.
Chen L; Cao J; Cao D; Wang M; Xiang H; Yang Y; Ying T; Cong H
Life Sci; 2019 Oct; 235():116553. PubMed ID: 31185237
[TBL] [Abstract][Full Text] [Related]
18. Dexmedetomidine reduces propofol-induced hippocampal neuron injury by modulating the miR-377-5p/Arc pathway.
Chen Z; Ding Y; Zeng Y; Zhang XP; Chen JY
BMC Pharmacol Toxicol; 2022 Mar; 23(1):18. PubMed ID: 35337381
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine inhibits inflammatory response and oxidative stress through regulating miR-205-5p by targeting HMGB1 in cerebral ischemic/reperfusion.
Yang JJ; Zhao YH; Yin KW; Zhang XQ; Liu J
Immunopharmacol Immunotoxicol; 2021 Aug; 43(4):478-486. PubMed ID: 34196265
[TBL] [Abstract][Full Text] [Related]
20. Curcumin protects PC12 cells from a high glucose-induced inflammatory response by regulating the miR-218-5p/TLR4 axis.
Cui Y; Song HT; Zhang P; Yin X; Wang Y; Wei X; Jia XJ
Medicine (Baltimore); 2022 Oct; 101(40):e30967. PubMed ID: 36221434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
